INDIANAPOLIS - Indianapolis-based Eli Lilly and Company is restructuring part of its drug product manufacturing. As a result, up to 100 jobs in central Indiana will be cut. However, those jobs will not be entirely lost, officials said Friday.
Patent expirations were the reason behind the cuts and the changes will take place over the next several years.
Company officials said while jobs will be lost with certain products in the pipeline, there will be new opportunities within the company for new products coming soon.
"This transition will take several years to implement. Employees affected by this plan will have opportunities to move elsewhere within manufacturing, such as our growing insulin and biotechnology areas. As previously announced, Lilly continues to advance insulin-related investments in Indianapolis totaling nearly half a billion dollars to expand insulin active ingredient and drug product manufacturing capacity," a spokesman said in a statement.
Watch RTV6 and refresh this page for updates.
Police chase ends in fatal crash near I-70
A police chase ended Tuesday night in a fatal crash on I-70.
Service dog saves family from morning house fire
A member of one south side Indianapolis family is credited with saving their lives after flames tore through a house early Tuesday morning.
$60M apartment & retail project coming to Carmel
A $60 million apartment, retail and office project is coming to Carmel.
Greenfield adult care accused of being unsafe
The owners of Greenfield adult care facility are accused of keeping patients in unsafe and unsanitary conditions.
Where truck crashes happen, how to avoid them
It's a weekly occurrence: A semi-truck crash shuts down an interstate for hours. People are hurt, or killed. Sometimes damage is caused…